PRS
BBH icon

Pinkerton Retirement Specialists’s VanEck Biotech ETF BBH Stock Holding History

Pinkerton Retirement Specialists’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-238
Closed -$29K – 189
2018
Q1 		$29K Hold
238
– – 0.01% 102
2017
Q4 		$30K Hold
238
– – 0.01% 114
2017
Q3 		$32K Hold
238
– – 0.02% 82
2017
Q2 		$30K Buy
+238
New +$28.7K 0.02% 85

Other funds holding BBH

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Pinkerton Retirement Specialists's BBH Position: Q2 2018 in Review

Pinkerton Retirement Specialists sold out of VanEck Biotech ETF (BBH) in Q2 2018, closing a stake of 238 shares — an estimated $29K sold.

Pinkerton Retirement Specialists first reported a position in BBH in Q2 2017 and held it in 4 quarters. The position peaked at $32K in Q3 2017. 83 funds tracked by Wall St. Rank hold BBH as of Q2 2018.

  • Pinkerton Retirement Specialists reported no remaining VanEck Biotech ETF position as of Q2 2018 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 238 VanEck Biotech ETF shares in Q2 2018, an estimated $29K.
  • Pinkerton Retirement Specialists first reported a position in VanEck Biotech ETF in Q2 2017 and held it in 4 quarters.
  • Pinkerton Retirement Specialists's VanEck Biotech ETF position peaked at $32K in Q3 2017.
  • 83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2018.

Based on Pinkerton Retirement Specialists's 13F filing for Q2 2018, filed 13 Aug 2018.